Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

The following is a summary of “Factors associated with the detection of atrial fibrillation in patients with embolic stroke ...

Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation ...

US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...

Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...

These documents have become too technical, too inconsistent, and rely too much on expert opinion, Marco Valgimigli argues.

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.

controlled study to evaluate the efficacy and safety of the atrial fibrillation (AF) Suppression Algorithm (St. Jude Medical, Cardiac Rhythm Management Division, Sylmar, CA) in patients with sick ...

Hein J. J. Wellens, M.D., F.A.C.C.; Sidney C. Smith, Jr., M.D., F.A.C.C. Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, accounting ...

MIAMI - Pulse Biosciences, Inc. (NASDAQ:PLSE), a biotech company with a market capitalization of $1.08 billion and an ...

Hypertension, atrial fibrillation, and smoking are strongly associated with an increased risk for severe vs nonsevere stroke.